Intercontinental spread of pyrimethamine-resistant malaria.
about
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumChallenges of drug-resistant malariaMalaria in the Greater Mekong Subregion: heterogeneity and complexityArtemisinin Resistance in Plasmodium falciparum MalariaA molecular marker of artemisinin-resistant Plasmodium falciparum malariaGlobal transport networks and infectious disease spreadEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaGenome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasitesPlasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugsMolecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug ProductionAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR NetworkMonitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in TanzaniaDrug resistance genomics of the antimalarial drug artemisininMitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systemsGlobal traffic and disease vector dispersalEstimating the malaria risk of African mosquito movement by air travelStructural polymorphism in the promoter ofpfmrp2confersPlasmodium falciparumtolerance to quinoline drugsGenetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapyTemporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaTreatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant allelesIncreasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western KenyaFrequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, YemenIncreased Prevalence of Mutant Allele Pfdhps 437G and Pfdhfr Triple Mutation in Plasmodium falciparum Isolates from a Rural Area of Gabon, Three Years after the Change of Malaria Treatment PolicyHigh efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studiesLow-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, AngolaA systematic map of genetic variation in Plasmodium falciparumChloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparumRapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial useAdvances in understanding the genetic basis of antimalarial drug resistanceOrigin and evolution of sulfadoxine resistant Plasmodium falciparumAdaptive copy number evolution in malaria parasitesMultiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malariaLong- and short-term selective forces on malaria parasite genomesEffects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamineFive years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll outIn vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genesCurrent status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in BangladeshSurveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countriesA population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition
P2860
Q21032477-FEDA00D8-7E02-40CF-99EA-B02605442444Q21032482-883D1387-B8CB-49CA-BAC9-AD7827013D1EQ21032492-0B7EEDA6-D443-4C05-8F29-A60CD2CB7F2AQ22061852-D9A0939E-FAFE-4EB8-B3A7-C11C71528E82Q22061872-36AE60F5-D88F-4A67-BC6B-A8BF076B815AQ24576083-405FACB3-FF31-4B94-902A-9943764AE90EQ24598695-578C04AE-CD1D-40C9-BBED-3A4072220C16Q24614989-7D6B71F1-4784-4F2B-9BD0-E97AF9E2B8F9Q24625172-EA98C265-5A45-4A34-AD5C-E2FAA7807BA7Q24642214-5671B8F8-B60A-4CC0-A3A3-0D30FDFB806FQ26752273-2E671F8D-2EAA-45F8-828D-3B2AA6702B22Q26799713-C5E3902C-A664-4351-B4AF-13D092D235EAQ26820807-1871AD55-7539-40FA-9D34-3B6E41DE1C5DQ26862789-A172D4E9-72AF-43AB-BBFB-794A7D08AF9CQ27000750-EEB88CC7-3B40-4AD7-B1BA-1EF029FF6C24Q27473134-AF8796C0-95A6-4808-8DF2-284FCE82524EQ27473562-ED97D233-6B66-4CDA-81E6-9D6CAAFF5350Q27861940-793C47CC-F65C-4A5F-A081-B7F83D5DED07Q28125913-4AFD8AF4-FC7B-4FF1-B704-6924B6ADFDECQ28125914-E54860B5-604B-401F-8110-7CA798E4F842Q28125916-FA646E8C-046B-4442-894E-46A769B19AA2Q28125918-D00D0A32-64E4-45F1-A3FA-5E865C967032Q28125931-A0B5EC42-E821-43D8-BE65-E8FDE3634203Q28125934-0B42A369-B978-4A0E-8606-8817E67C4B17Q28125935-EF5CC786-B161-44E7-9B43-9803B4D914A0Q28125937-B84E2341-723D-484E-9711-8B3CA95AF233Q28469012-2CD43CCC-DA99-4B11-8EFC-5BC9060033E3Q28469025-1999933F-AC73-48CF-9D65-DDFFE91BB562Q28469104-25C16C25-697B-467D-B235-6F542CD889E5Q28471642-04E82B9A-E395-4BFC-B207-4694168C43C4Q28473479-914BF7CB-8E43-4519-8F6A-6133BE844DFEQ28473933-8D8E6212-50AD-4740-82D3-6B9499AA9CBEQ28475195-28D7EBE4-D92A-4EF7-9635-1729F78E2C9BQ28475448-59875CCB-4F0F-4BF6-80B4-A922863C12BEQ28476005-72D93DD3-9D2E-4184-A688-FE946D58ADF8Q28477515-11C867EB-03AF-480A-B423-68D4CE552064Q28484068-5469B3E1-2170-4B44-AB22-382704FC284BQ28484416-5E287CC2-5404-45EC-A5D3-A70E6296A49CQ28534753-A0EC07DB-8CCB-44EB-86CA-5CB301113F4DQ28540567-01944EAD-9D93-487C-84BD-EB7B10F56882
P2860
Intercontinental spread of pyrimethamine-resistant malaria.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Intercontinental spread of pyrimethamine-resistant malaria.
@en
Intercontinental spread of pyrimethamine-resistant malaria.
@nl
type
label
Intercontinental spread of pyrimethamine-resistant malaria.
@en
Intercontinental spread of pyrimethamine-resistant malaria.
@nl
prefLabel
Intercontinental spread of pyrimethamine-resistant malaria.
@en
Intercontinental spread of pyrimethamine-resistant malaria.
@nl
P2093
P50
P356
P1433
P1476
Intercontinental spread of pyrimethamine-resistant malaria.
@en
P2093
Brian Sharp
Richard Pearce
Tim Anderson
P356
10.1126/SCIENCE.1098876
P407
P577
2004-08-01T00:00:00Z